Copertina

Inmunoprotección activa contra cocaína

Fuente: Redalyc

Salvato in:

Dettagli Bibliografici
Autore principale:	Alberto Salazar-Juárez
Natura:	Artículo científico
Lingua:	es
Pubblicazione:	Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz 2015
Soggetti:	Medicina cocaine Addiction protection active immune antibodies and pharmacotherapies
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Serosurveillance for vaccine-preventable diseases: A look inside the pertussis experience
di: Doracelly Hincapié-Palacio
Pubblicazione: (2019)

Hepatitis C: clinical and biological features related to different forms of cocaine use
di: Silvia Bassani Schuch-Goi
Pubblicazione: (2017)

Competencia y compartimiento emocional en usuarios de cocaína: Psicometría y relación con variables sociodemográficas y clínicas
di: Beatriz A. Corona-Figueroa
Pubblicazione: (2015)

Oxford Open Immunology
Pubblicazione: (2021)

Long-term randomized clinical trials of pharmacological treatment of obesity: Systematic review
di: LIDIA CASTAÑEDA-GONZÁLEZ
Pubblicazione: (2010)

Role of Intensive Counseling in Smoking Cessation. A Multicausal Prospective Study in the Primary Care Setting
di: S Afek
Pubblicazione: (2007)

Barbiturates and valproates in the pharmacotherapy of epilepsy: clinical and psychological interactions
di: Natalia Tokareva
Pubblicazione: (2021)

Factores asociados al consumo de cocaína en usuarios de heroína inyectable en Colombia
di: Dedsy Yajaira Berbesi-Fernández
Pubblicazione: (2016)

Validation of a cocaine craving questionnaire (CCQ-G) in Mexican population
di: Rodrigo Marín-Navarrete
Pubblicazione: (2011)

Prevalence of adjunctive antipsychotic treatment for non-psychotic predominantly Latino depressed adults: a retrospective study.
di: Osama A. Abulseoud
Pubblicazione: (2013)

Community-acquired pneumonia: the dynamics of senior medical students’ knowledge
di: Anna A Gavrilova
Pubblicazione: (2020)

Neurobiology of addiction: neuroanatomical, neurochemical, molecular and genetic aspects of morphine and cocaine addiction. Part III
di: Armando Valdez
Pubblicazione: (2000)

Neurobiology of addiction neuroanatomical, neurochemical, molecular and genetic aspects of morphine and cocaine addiction. Part I
di: Ma. Elena Medina
Pubblicazione: (2000)

Dual disorders in individuals under treatment for both alcohol and cocaine: Madrid study on the prevalence of dual disorders
di: José Luis Palomo
Pubblicazione: (2017)

Figure 4 from: Atanasov PY, Kobakova YA, Moneva-Sakelarieva MG, Ivanova SA, Chaneva MS, Atanasova VP, Todorov RF, Bashev NZ, Kirkova-Bogdanova AG, Vakrilova Becheva M (2025) Assessment of the therapeutic effect and subsequent immune response in the treatment of COVID-19 with anti-SARS-CoV-2 monoclonal antibodies. Pharmacia 72: 1-7. https://doi.org/10.3897/pharmacia.72.e154298
di: Atanasov, Petar Yordanov, et al.
Pubblicazione: (2025)

Characteristics and complications of acute cocaine intoxication. A cross-sectional study in an emergency room in Colombia
di: LAURA JIMÉNEZ-OSPINA
Pubblicazione: (2022)

Etat limite, adolescence, cannabis et cocaïne
di: Didier Lauru
Pubblicazione: (2014)

Antibodies
Pubblicazione: (2012)

Figure 6 from: Guan X, Lv X, Yu S, Fan G, Min J, Song Y, Zhao W, Liu L, Zhang M, Zhao H, Huang J, Wang J (2026) Immune-regulating complex orchestrates protection against sepsis. Pharmacia 73: 1-10. https://doi.org/10.3897/pharmacia.73.e180793
di: Guan, Xinxian, et al.
Pubblicazione: (2026)

Profile and pattern of crack consumption among inpatients in a Brazilian psychiatric hospital
di: Silvia Mendes da Cunha
Pubblicazione: (2015)

L-6 and IL-10 levels in the umbilical cord blood of newborns with a history of crack/cocaine exposure in utero: a comparative study
di: Victor Mardini
Pubblicazione: (2016)

Two interconnected worlds: How exposure to social stress makes us more vulnerable to drug use
di: Sandra Montagud-Romero
Pubblicazione: (2022)

Depression, anxiety, hopelessness and quality of life in users of cocaine/crack in outpatient treatment
di: Camila Bosse Paiva
Pubblicazione: (2017)

Main mental disorders in crack-cocaine users treated at Psychosocial Care Centers for Alcohol and Drugs in the city of Recife, Brazil
di: Antonio Gomes de Castro Neto
Pubblicazione: (2016)

Atypical hemolytic-uremic syndrome (aHUS)
di: Gustavo Adolfo Domínguez-Ramírez
Pubblicazione: (2019)

Journal of Human Immunity
Pubblicazione: (2025)

Farmacist.ro
Pubblicazione: (2021)

The trajectory of crack users to the street situation in the perspective of family members
di: Maycon Rogério Seleghim
Pubblicazione: (2019)

mAbs
Pubblicazione: (2021)

Current Research in Pharmacology and Drug Discovery
Pubblicazione: (2021)

Journal of Experimental Pharmacology
Pubblicazione: (2021)

Monoclonal antibody-based rabies immunotherapy
di: Vishav Bharti
Pubblicazione: (2025)

Influence of the family environment on individuals who use crack
di: Maycon Rogério Seleghim
Pubblicazione: (2013)

CCR5 Blockade, PD-L1 Modulation, IL-1Ra Axis Restoration, and bNAbs
di: Daniel, Rizzo
Pubblicazione: (2025)

Initial psychometric properties of the Inventory of Anticipatory Coping Skills for Abstinence from Alcohol and Other Drugs
di: Lucas Guimarães Cardoso de Sá
Pubblicazione: (2017)

Prevalence of thyroid autoimmunity in a population of pregnant women in Santa Marta, Magdalena (Colombia)
di: Carla Lorena Macchia de Sánchez
Pubblicazione: (2018)

Presence of autoantibodies and epidemiological characteristics of systemic sclerosis patients in western Paraná
di: Alana Rubia Balbinot
Pubblicazione: (2023)

Amyloid-beta immunotherapy: the hope for Alzheimer disease?
di: Alvaro Barrera-Ocampo
Pubblicazione: (2016)

Безопасность и риск фармакотерапии
Pubblicazione: (2018)

Clinical and Translational Gastroenterology
Pubblicazione: (2012)